• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于精神分裂症的卡尔加里抑郁评定量表:德文版(CDSS-G)的编制及评分者间信度

The Calgary Depression Rating Scale for Schizophrenia: development and interrater reliability of a German version (CDSS-G).

作者信息

Müller M J, Marx-Dannigkeit P, Schlösser R, Wetzel H, Addington D, Benkert O

机构信息

Department of Psychiatry, University of Mainz, Germany.

出版信息

J Psychiatr Res. 1999 Sep-Oct;33(5):433-43. doi: 10.1016/s0022-3956(99)00018-7.

DOI:10.1016/s0022-3956(99)00018-7
PMID:10504012
Abstract

A German version of the Calgary Depression Rating Scale for Schizophrenia (CDSS-G) approved by the author of the original scale is presented comprising a semi-structured interview for 9 items to sensitively and specifically assess depression in schizophrenia and related disorders. The process of translation is outlined and the finally derived CDSS-G was investigated with respect to interrater reliability in three studies. To keep comparability with the CDSS source version a standard procedure was used. Two trained raters jointly assessed ten schizophrenic patients (study I). In a second study, videotapes with the CDSS-G were presented to clinically inexperienced raters (study II, N = 14/15) to test the agreement on the CDSS-G in this sample. Finally, in a third study clinically experienced researchers participated in a rater training (study III, N = 34). They carried out CDSS ratings on three patients with mild depressive symptoms. The dependence of interrater reliability on depression severity was investigated for all studied patients. Both intraclass correlation coefficients (ICC) and weighted kappa coefficients (kappa(w)) were calculated. The results revealed a high ICC = 0.97 in study I for the total CDSS-G score. Single item ICC values were all above 0.70. The results of study II revealed somewhat lower agreement on CDSS-G items and total scores in psychiatric novices with however acceptable values of kappa(w)>0.50 for the total scores. Study III yielded satisfactory results (0.66<kappa(w)<0.76) for clinically experienced psychiatrists in schizophrenic patients with mild depression. The results demonstrate adequate to excellent interrater reliability of the CDSS-G corroborating the results of the original version in different settings.

摘要

本文呈现了经原量表作者认可的德语版《卡尔加里精神分裂症抑郁评定量表》(CDSS-G),它包含一个针对9个条目的半结构化访谈,用于敏感且特异的评估精神分裂症及相关障碍中的抑郁症状。文中概述了翻译过程,并在三项研究中对最终得出的CDSS-G进行了评分者间信度的调查。为保持与CDSS源版本的可比性,采用了标准程序。两名经过培训的评分者共同评估了10名精神分裂症患者(研究I)。在第二项研究中,向临床经验不足的评分者展示了CDSS-G的录像带(研究II,N = 14/15),以测试该样本中对CDSS-G的一致性。最后,在第三项研究中,有临床经验的研究人员参与了评分者培训(研究III,N = 34)。他们对三名有轻度抑郁症状的患者进行了CDSS评分。针对所有研究患者,调查了评分者间信度对抑郁严重程度的依赖性。计算了组内相关系数(ICC)和加权kappa系数(kappa(w))。结果显示,在研究I中,CDSS-G总分的ICC高达0.97。单个条目的ICC值均高于0.70。研究II的结果显示,精神科新手对CDSS-G条目和总分的一致性略低,但总分的kappa(w)>0.50仍在可接受范围内。对于患有轻度抑郁症的精神分裂症患者,研究III为有临床经验的精神科医生提供了满意的结果(0.66<kappa(w)<0.76)。结果表明,CDSS-G具有足够至优异的评分者间信度,在不同环境下证实了原始版本的结果。

相似文献

1
The Calgary Depression Rating Scale for Schizophrenia: development and interrater reliability of a German version (CDSS-G).用于精神分裂症的卡尔加里抑郁评定量表:德文版(CDSS-G)的编制及评分者间信度
J Psychiatr Res. 1999 Sep-Oct;33(5):433-43. doi: 10.1016/s0022-3956(99)00018-7.
2
Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia.《卡尔加里精神分裂症抑郁量表西班牙语版的跨文化改编与验证》
Schizophr Res. 2004 Jun 1;68(2-3):349-56. doi: 10.1016/S0920-9964(02)00490-5.
3
Calgary Depression Scale for Schizophrenia: a study of the validity of a French-language version in a population of schizophrenic patients.《卡尔加里精神分裂症抑郁量表:法语版在精神分裂症患者群体中的效度研究》
Acta Psychiatr Scand. 1998 Jan;97(1):36-41. doi: 10.1111/j.1600-0447.1998.tb09960.x.
4
The Calgary Depression Rating Scale for schizophrenia in a healthy control group: psychometric properties and reference values.健康对照组中用于精神分裂症的卡尔加里抑郁评定量表:心理测量特性及参考值
J Affect Disord. 2005 Sep;88(1):69-74. doi: 10.1016/j.jad.2005.04.005.
5
Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS).精神分裂症患者卡尔加里抑郁量表(CDSS)的同时效度研究。
J Affect Disord. 2000 May;58(2):107-15. doi: 10.1016/s0165-0327(99)00075-0.
6
The Greek version of the calgary depression scale for schizophrenia.精神分裂症卡尔加里抑郁量表希腊语版本。
Psychiatry Res. 2000 May 15;94(2):163-71. doi: 10.1016/s0165-1781(00)00137-2.
7
[Interrater reliability of the German version of the Comprehensive Psychopathological Rating Scale (CPRS)].
Int Pharmacopsychiatry. 1982;17(4):354-69. doi: 10.1159/000468590.
8
Validity study of the Brazilian version of the Calgary Depression Scale for Schizophrenia.巴西版精神分裂症卡尔加里抑郁量表的效度研究。
Schizophr Res. 1998 Jun 22;32(1):41-9. doi: 10.1016/s0920-9964(98)00029-2.
9
Interrater reliability of the Structured Clinical Interview for the Positive and Negative Syndrome Scale for schizophrenia.精神分裂症阳性和阴性症状量表结构化临床访谈的评分者间信度。
Acta Psychiatr Scand. 1994 Mar;89(3):192-5. doi: 10.1111/j.1600-0447.1994.tb08091.x.
10
The Persian version of the Calgary Depression Scale for Schizophrenia (CDSS-P).《精神分裂症卡尔加里抑郁量表(CDSS-P)》的波斯语版本。
Asian J Psychiatr. 2019 Oct;45:44-49. doi: 10.1016/j.ajp.2019.08.017. Epub 2019 Aug 30.

引用本文的文献

1
Clinical deep phenotyping of treatment response in schizophrenia (CDP-STAR): design and methodology of a prospective multimodal observational study.精神分裂症治疗反应的临床深度表型分析(CDP-STAR):一项前瞻性多模态观察性研究的设计与方法
Eur Arch Psychiatry Clin Neurosci. 2025 Sep 8. doi: 10.1007/s00406-025-02100-1.
2
Level of structural integration in people with schizophrenia and schizoaffective disorders - applicability and associations with clinical parameters.精神分裂症和分裂情感性障碍患者的结构整合水平——适用性及其与临床参数的关联
Front Psychiatry. 2024 Jun 6;15:1388478. doi: 10.3389/fpsyt.2024.1388478. eCollection 2024.
3
Empathy in schizophrenia: neural alterations during emotion recognition and affective sharing.
精神分裂症中的同理心:情绪识别和情感共享过程中的神经改变。
Front Psychiatry. 2024 May 24;15:1288028. doi: 10.3389/fpsyt.2024.1288028. eCollection 2024.
4
Cannabidiol versus placebo as adjunctive treatment in early psychosis: study protocol for randomized controlled trial.大麻二酚作为早期精神病辅助治疗的对照研究:随机对照试验研究方案。
Trials. 2023 Nov 30;24(1):775. doi: 10.1186/s13063-023-07789-w.
5
The multimodal Munich Clinical Deep Phenotyping study to bridge the translational gap in severe mental illness treatment research.多模式慕尼黑临床深度表型研究,以弥合严重精神疾病治疗研究中的转化差距。
Front Psychiatry. 2023 May 5;14:1179811. doi: 10.3389/fpsyt.2023.1179811. eCollection 2023.
6
"Goals in Focus"-a targeted CBT approach for motivational negative symptoms of psychosis: study protocol for a randomized-controlled feasibility trial.“聚焦目标”——一种针对精神病性动机性阴性症状的认知行为疗法:一项随机对照可行性试验的研究方案
Pilot Feasibility Stud. 2023 May 2;9(1):72. doi: 10.1186/s40814-023-01284-4.
7
Thematic analysis of the raters' experiences administering scales to assess depression and suicide in Arab schizophrenia patients.对评估阿拉伯精神分裂症患者抑郁和自杀的量表进行评估的评分者的体验进行主题分析。
BMC Psychiatry. 2022 Oct 21;22(1):652. doi: 10.1186/s12888-022-04313-3.
8
Feasibility and efficacy of an acceptance and mindfulness-based group intervention for young people with early psychosis (Feel-Good group).一项针对早期精神病患者的基于接纳与正念的团体干预(感觉良好团体)的可行性和有效性。
Front Psychiatry. 2022 Sep 16;13:943488. doi: 10.3389/fpsyt.2022.943488. eCollection 2022.
9
Association between depressive symptoms and cognitive-behavioural therapy receipt within a psychosis sample: a cross-sectional study.抑郁症状与精神病样本中认知行为治疗接受度之间的关联:一项横断面研究。
BMJ Open. 2022 May 10;12(5):e051873. doi: 10.1136/bmjopen-2021-051873.
10
Depression: An actionable outcome for those at clinical high-risk.抑郁:临床高风险人群的可干预结局。
Schizophr Res. 2021 Jan;227:38-43. doi: 10.1016/j.schres.2020.10.001. Epub 2020 Oct 29.